We are live on ! Find out more
VKH

Virtu KCG Holdings Portfolio holdings

AUM $3.6B
1-Year Est. Return 17.11%
This Fund
S&P 500
This Quarter Est. Return
+3.33%
1 Year Est. Return
+17.11%
3 Year Est. Return
+11.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.06B
AUM Growth
-$150M
Cap. Flow
-$263M
Cap. Flow %
-6.49%
Top 10 Hldgs %
31.74%
Holding
4,242
New
1,199
Increased
1,051
Reduced
1,075
Closed
887

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$13.6M
2
SJB icon
ProShares Short High Yield
SJB
+$12.8M
3
MSFT icon
Microsoft
MSFT
+$10.1M
4
BAC icon
Bank of America
BAC
+$9.91M
5
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$9.35M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$86.4M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$29.1M
3
DEM icon
WisdomTree Emerging Markets High Dividend Fund
DEM
+$28.2M
4
GS icon
Goldman Sachs
GS
+$19.2M
5
WFC icon
Wells Fargo
WFC
+$14.1M

Sector Composition

Rank Sector Weight
1 Financials 8.67%
2 Technology 5.57%
3 Industrials 5.45%
4 Consumer Discretionary 5.35%
5 Healthcare 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LSTA icon
3051
Lisata Therapeutics
LSTA
$9.02M
$59K ﹤0.01%
+1,386
New +$79.6K
NBSE
3052
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$59K ﹤0.01%
+98
New +$104K
AXU
3053
DELISTED
Alexco Resource Corp
AXU
$59K ﹤0.01%
+44,031
New +$67.8K
OREX
3054
DELISTED
Orexigen Therapeutics, Inc.
OREX
$59K ﹤0.01%
33,815
+10,193
+43% +$24K
ABUS icon
3055
Arbutus Biopharma
ABUS
$857M
$58K ﹤0.01%
23,700
-5,857
-20% -$17K
ADVM
3056
DELISTED
Adverum Biotechnologies
ADVM
$58K ﹤0.01%
1,995
+789
+65% +$25.8K
GLDD
3057
DELISTED
Great Lakes Dredge & Dock
GLDD
$58K ﹤0.01%
13,791
-379
-3% -$1.54K
CYTR
3058
DELISTED
CytRx Corp
CYTR
$58K ﹤0.01%
+26,021
New +$76.5K
CPRX
3059
DELISTED
Catalyst Pharmaceutical
CPRX
$57K ﹤0.01%
+54,200
New +$61.9K
FATE icon
3060
Fate Therapeutics
FATE
$286M
$57K ﹤0.01%
22,716
+9,368
+70% +$25.1K
INVE icon
3061
Identive
INVE
$63.4M
$57K ﹤0.01%
18,039
+4,981
+38% +$13.3K
CBK
3062
DELISTED
Christopher & Banks Corporation
CBK
$57K ﹤0.01%
24,274
+3,948
+19% +$6.76K
VNR
3063
DELISTED
Vanguard Natural Resources, LLC
VNR
$57K ﹤0.01%
85,262
-108,417
-56% -$78.4K
CARM
3064
DELISTED
Carisma Therapeutics
CARM
$56K ﹤0.01%
1,474
-3,425
-70% -$151K
IMBI
3065
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$56K ﹤0.01%
3,744
+870
+30% +$16.4K
AREX
3066
DELISTED
Approach Resources Inc.
AREX
$56K ﹤0.01%
+16,797
New +$54.7K
VISL
3067
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$56K ﹤0.01%
34
+21
+162% +$84.9K
FCRE
3068
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
$56K ﹤0.01%
25,339
+10,157
+67% +$19.4K
QMCO icon
3069
Quantum Corp
QMCO
$419M
$55K ﹤0.01%
416
-646
-61% -$84.6K
XOMA
3070
DELISTED
Xoma
XOMA
$55K ﹤0.01%
13,132
+2,432
+23% +$15.1K
CTG
3071
DELISTED
Computer Task Group, Inc.
CTG
$55K ﹤0.01%
+13,037
New +$57.4K
NOG icon
3072
Northern Oil and Gas
NOG
$2.3B
$54K ﹤0.01%
1,971
-11,561
-85% -$275K
CATX icon
3073
Perspective Therapeutics
CATX
$332M
$53K ﹤0.01%
+9,116
New +$55.8K
DHT icon
3074
DHT Holdings
DHT
$2.99B
$53K ﹤0.01%
12,850
-141,857
-92% -$563K
LRMR icon
3075
Larimar Therapeutics
LRMR
$397M
$53K ﹤0.01%
1,379
-3,710
-73% -$150K
121 122
123
124 125

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.21% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
RBC
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return
GA
Geneva Advisors Chicago, Illinois $5.81B AUM 23.71% 1-Year Est. Return

Virtu KCG Holdings's Q4 2016 Portfolio in Review

As of Q4 2016, Virtu KCG Holdings held 4,242 positions worth $4.06B, down 3.6% from $4.21B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Virtu KCG Holdings withdrew a net $263M in Q4 2016, closing 887 positions and reducing 1,075 holdings. Its most notable exit was WisdomTree Emerging Markets High Dividend Fund, an estimated $28.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 8.7% of assets, up from 7% a quarter earlier, followed by Technology and Industrials.

Against the trend, Virtu KCG Holdings opened a new position in Citigroup worth $14.9M.

  • Virtu KCG Holdings's largest Q4 2016 buy was Citigroup: 251,435 shares worth $14.9M.
  • Virtu KCG Holdings added most to Microsoft in Q4 2016, an estimated $10.1M increase.
  • Virtu KCG Holdings's biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $86.4M.
  • Virtu KCG Holdings fully exited WisdomTree Emerging Markets High Dividend Fund in Q4 2016, selling an estimated $28.2M.
  • Virtu KCG Holdings's ten largest holdings make up 32% of its $4.06B portfolio in Q4 2016.
  • Virtu KCG Holdings opened 1,199 new positions and closed 887 in Q4 2016.
  • Virtu KCG Holdings's portfolio value fell 3.6% quarter-over-quarter to $4.06B.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.